154 related articles for article (PubMed ID: 22311732)
1. Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts.
Koka S; Xi L; Kukreja RC
Basic Res Cardiol; 2012 Mar; 107(2):249. PubMed ID: 22311732
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice.
Koka S; Das A; Salloum FN; Kukreja RC
Free Radic Biol Med; 2013 Jul; 60():80-8. PubMed ID: 23385031
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.
Koka S; Aluri HS; Xi L; Lesnefsky EJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2014 Jun; 306(11):H1558-68. PubMed ID: 24727492
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy.
Jin Z; Zhang J; Zhi H; Hong B; Zhang S; Guo H; Li L
J Cardiol; 2013 Aug; 62(2):110-6. PubMed ID: 23731918
[TBL] [Abstract][Full Text] [Related]
5. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
Koka S; Xi L; Kukreja RC
Mol Cell Biochem; 2020 May; 468(1-2):47-58. PubMed ID: 32162053
[TBL] [Abstract][Full Text] [Related]
8. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
[TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.
Das A; Durrant D; Koka S; Salloum FN; Xi L; Kukreja RC
J Biol Chem; 2014 Feb; 289(7):4145-60. PubMed ID: 24371138
[TBL] [Abstract][Full Text] [Related]
10. Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury.
Ahmad N; Wang Y; Ali AK; Ashraf M
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H387-91. PubMed ID: 19429825
[TBL] [Abstract][Full Text] [Related]
11. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
[TBL] [Abstract][Full Text] [Related]
12. Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect.
Koka S; Das A; Zhu SG; Durrant D; Xi L; Kukreja RC
J Pharmacol Exp Ther; 2010 Sep; 334(3):1023-30. PubMed ID: 20543097
[TBL] [Abstract][Full Text] [Related]
13. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
14. Short-term exercise worsens cardiac oxidative stress and fibrosis in 8-month-old db/db mice by depleting cardiac glutathione.
Laher I; Beam J; Botta A; Barendregt R; Sulistyoningrum D; Devlin A; Rheault M; Ghosh S
Free Radic Res; 2013 Jan; 47(1):44-54. PubMed ID: 23039789
[TBL] [Abstract][Full Text] [Related]
15. Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion.
De Celle T; Vanrobaeys F; Lijnen P; Blankesteijn WM; Heeneman S; Van Beeumen J; Devreese B; Smits JF; Janssen BJ
Exp Physiol; 2005 Jul; 90(4):593-606. PubMed ID: 15833752
[TBL] [Abstract][Full Text] [Related]
16. Long-acting PDE5 inhibitor tadalafil prevents early doxorubicin-induced left ventricle diastolic dysfunction in juvenile mice: potential role of cytoskeletal proteins.
Nagiub M; Filippone S; Durrant D; Das A; Kukreja RC
Can J Physiol Pharmacol; 2017 Mar; 95(3):295-304. PubMed ID: 28238269
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of endoplasmic reticulum chaperone GRP78 in liver of diabetic mice.
Yamagishi N; Ueda T; Mori A; Saito Y; Hatayama T
Biochem Biophys Res Commun; 2012 Jan; 417(1):364-70. PubMed ID: 22155243
[TBL] [Abstract][Full Text] [Related]
18. Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension.
Arif SA; Poon H
Clin Ther; 2011 Aug; 33(8):993-1004. PubMed ID: 21762988
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling.
Chu G; Kerr JP; Mitton B; Egnaczyk GF; Vazquez JA; Shen M; Kilby GW; Stevenson TI; Maggio JE; Vockley J; Rapundalo ST; Kranias EG
FASEB J; 2004 Nov; 18(14):1725-7. PubMed ID: 15358683
[TBL] [Abstract][Full Text] [Related]
20. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
Zhao X; Ramsey KE; Stephan DA; Russell P
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
